In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cutanea Life Sciences Inc.

www.cutanealife.com

Latest From Cutanea Life Sciences Inc.

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.

Deals Commercial

Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis

Biohaven restructures its migraine partnership with Bristol to reduce its downstream royalty commitments. Meanwhile, the pharma partners with GRYT Health's cancer app for patient/caregiver insights into cancer therapy.

Deals M & A

Bitterman and Brownlie join board at RXi

RNAi therapeutics company RXi Pharmaceuticals has appointed Robert Bitterman and Keith Brownlie to its board of directors. Mr Bitterman currently serves as president and CEO of Cutanea Life Sciences, a wholly owned subsidiary of Maruho Company. Mr Brownlie joins RXi following a 36-year career at Ernst & Young. For the last 20 years before his retirement in 2010, he was Metro New York Area Life Sciences Industry Leader at the company. Mr Brownlie also serves on the boards of Epicept and Soligenix.

Japanese Specialty Pharma Maruho Acquires Cutanea Of U.S.

Osaka-based Maruho Co., Ltd has acquired Cutanea Life Sciences Inc., a U.S. private dermatology development company based in Pennsylvania.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cutanea Life Sciences Inc.
  • Senior Management
  • Robert J Bitterman, Pres. & CEO
    James McMonagle, Interim CFO
  • Contact Info
  • Cutanea Life Sciences Inc.
    Phone: (484) 588-2036
    1500 Liberty Ridge Dr
    Ste. 300
    Wayne, PA 19087
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register